UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                   FORM 8-K

                             CURRENT REPORT PURSUANT
                          TO SECTION 13 OR 15(d) OF THE
                         SECURITIES EXCHANGE ACT OF 1934

         Date of report (Date of earliest event reported): May 15, 2007

                                  METLIFE, INC.
--------------------------------------------------------------------------------
        (Exact Name of Registrant as Specified in Its Charter)

         Delaware                  1-15787                     13-4075851
--------------------------------------------------------------------------------
(State or Other Jurisdiction      (Commission                  (IRS Employer
      of Incorporation)           File Number)               Identification No.)

 200 Park Avenue, New York, New York                    10166-0188
--------------------------------------------------------------------------------
(Address of Principal Executive Offices)                (Zip Code)

                                  212-578-2211
--------------------------------------------------------------------------------
              (Registrant's Telephone Number, Including Area Code)

                                       N/A
--------------------------------------------------------------------------------
        (Former Name or Former Address, if Changed Since Last Report)

    Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):

    [ ]   Written communications pursuant to Rule 425 under the Securities Act
          (17 CFR 230.425)

    [ ]   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17
          CFR 240.14a-12)

    [ ]   Pre-commencement communications pursuant to Rule 14d-2(b) under the
          Exchange Act (17 CFR 240.14d-2(b))

    [ ]   Pre-commencement communications pursuant to Rule 13e-4(c) under the
          Exchange Act (17 CFR 240.13e-4(c))



ITEM 8.01  OTHER EVENTS.

     On May 15, 2007, MetLife, Inc. (the "Company") issued a press release
announcing the declaration of second quarter 2007 dividends of $0.4060062 per
share on the Company's floating rate non-cumulative preferred stock, Series A,
and $0.4062500 per share on the Company's 6.50% non-cumulative preferred stock,
Series B. A copy of the press release is attached hereto as Exhibit 99.1 and is
incorporated herein by reference.


ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS.

   (a)          Not applicable

   (b)          Not applicable

   (c)          Not applicable

   (d)          Exhibits.

        99.1    Press release of MetLife, Inc., dated May 15, 2007,
                announcing the declaration of second quarter 2007 dividends
                on its floating rate non-cumulative preferred stock,
                Series A, and its 6.50% non-cumulative preferred stock,
                Series B.



                                   SIGNATURES

        Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

                                 METLIFE, INC.

                                 By: /s/ Gwenn L. Carr
                                     -------------------------------------------
                                     Name:  Gwenn L. Carr
                                     Title: Senior Vice-President and Secretary

Date: May 15, 2007



                                  EXHIBIT INDEX

 EXHIBIT
 NUMBER                                    EXHIBIT
--------                                   -------

  99.1         Press release of MetLife, Inc., dated May 15, 2007, announcing
               the declaration of second quarter 2007 dividends on its floating
               rate non-cumulative preferred stock, Series A, and its 6.50%
               non-cumulative preferred stock, Series B.